Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I know these are a FTSE 250 company but those trades of 100,000 and 160,000 trades are sizeable. Both look like buys as well which is some statement of confidence.
Because someone has been playing pin the tail on the Donkey Udg Healthcare PLC using EPIC/TICKER code (LON:UDG) has had its stock rating noted as ‘Downgrades’ with the recommendation being set at ‘HOLD’ today by analysts at Liberum Capital. Udg Healthcare PLC are listed in the Consumer Services sector within UK Main Market. Liberum Capital have set their target price at 884 GBX on its stock. This now indicates the analyst believes there is a possible upside of 7.3% from today’s opening price of 824 GBX. Over the last 30 and 90 trading days the company share price has decreased 26 points and increased 78 points respectively. The 52 week high share price is 886.5 GBX while the 52 week low for the stock is 596 GBX. Udg Healthcare PLC has a 50 day moving average of 848.58 GBX and the 200 Day Moving Average price is recorded at 739.69. There are currently 247,621,161 shares in issue with the average daily volume traded being 567,444. Market capitalisation for LON:UDG is £1,993,350,346 GBP.
Looking a bit sickly this morning after droppping almost 5%. Anyone know the reason behind the battering on a general uptick day for stocks?
Hi Storm. Good to see another poster on this. The share is still up 23% YTD as posted in Morningstars news update today. I think todays update for me is a good reason to top up on the dip as I think there's more to come for this company
tyneagle, Despite the excellent reports in February and May the sp has only gone up 5% since your last posting. There are un-fashionable companies, perhaps this is one of them.
I'm astonished how so few people seem to follow this company. Not a single post since mine following the excellent report in Feb and again today. Onward and upward methinks
A very encouraging set of figures. I really like what the future holds for this company. Definitely a good long term investment
2016 – The Great Irish Share Valuation Project (Part IV) Company: UDG Healthcare (UDG:LN) Last TGISVP Post: Here Market Cap: GBP 1,653 Million Price: GBP 668p https://wexboy.wordpress.com/2016/12/22/2016-the-great-irish-share-valuation-project-part-iv/ Price Target: GBP 387p Upside/(Downside): (42)%
If you read the footnotes of the Aquilant section in the RNS, it states a few times that real performance was behind that of last year, i can only imagine that it's profit taking or that news: "(2) Underlying growth adjusts for the impact of currency movements and any acquisition, closure or disposal activity. Revenue was 8% behind the prior year, however, adjusting for the closure of Aquilant's UK laboratory distribution business in February 2015 and negative currency movements, underlying revenue was in line with the prior year. Reported operating profit was 14% behind the prior year, primarily due to adverse currency movements and the timing of capital sales activity. Underlying operating profit was 2% (c. EUR0.2 million) behind the prior year."
drop - on those results??? am i missing something???
by Berenberg with a TP of 720p. Not sure what is behind's today's surge but perhaps it is reclaiming lost ground in the recent dip.
Having been a long term investor in UDG Healthcare it amazes me that there are never any posters here. Be good to hear from other investors on what they feel the future holds
UDG Healthcare Structural transformation boosted by good results Update | Pharmaceutical & Healthcare | 11/12/2015
Should I sell now!!!
This share price is artifically high - over 22 X earnings. There has been some recent dumping caused by one particular broker promoting selling. A few large trades in the last week including one of well over 1m share. What does that tell you?
<b>Analysts Set Udg Healthcare PLC PT at $408.00 (LON:UDG) March 21st, 2015 Updated Tues 25 March/2015 - Filed Under - by Samantha Reynolds</b> Shares of Udg Healthcare PLC (LON:UDG) have earned a consensus recommendation of “Buy” from the seven brokerages that are covering the company, American Banking & Market News reports. Three analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is GBX 408 ($6.02). Udg Healthcare PLC (LON:UDG) opened at 465.70 on Wednesday. Udg Healthcare PLC has a 52-week low of GBX 315.20 and a 52-week high of GBX 479.03. The stock’s 50-day moving average is GBX 445. and its 200-day moving average is GBX 378.. The company’s market cap is £1.13 billion. UDG has been the subject of a number of recent research reports. Analysts at N+1 Singer reiterated a “hold” rating on shares of Udg Healthcare PLC in a research note on Friday, March 6th. Analysts at Berenberg Bank raised their price target on shares of Udg Healthcare PLC from GBX 425 ($6.27) to GBX 455 ($6.71) and gave the company a “hold” rating in a research note on Thursday, February 12th. Analysts at Jefferies Group LLC reiterated a “buy” rating and set a GBX 400 ($5.90) price target on shares of Udg Healthcare PLC in a research note on Tuesday, February 3rd. Finally, analysts at Investec raised their price target on shares of Udg Healthcare PLC from GBX 340 ($5.02) to GBX 387 ($5.71) and gave the company a “hold” rating in a research note on Tuesday, February 3rd. UDG Healthcare plc is an international provider of services to healthcare manufacturers and pharmaceutical retailers. It is engaged in supply chain, packaging, medical, regulatory, and sales and marketing services. The Company provides outsourced services. Aquilant is a provider of healthcare and scientific products and services, providing outsource sales, marketing, distribution and engineering for the medical and scientific sectors.
UPDATE 2 – UDG Healthcare expects 5 – 8 pct rise in full – year EPS 03 Feb 2015 - 11:11 Says reported EPS to be higher if current exchange rates persist To take 10 mln euro restructuring charge this year Sees 2 pct benefit to EPS from restructuring Shares rise 5 pct to record high (Adds details, analyst and CFO comments; updates share movement) By Roshni Menon Feb 3 (Reuters) – UDG Healthcare Plc said it expected a 5-8 percent rise in adjusted full-year earnings per share on a constant-currency basis, and that reported EPS could be higher than this if exchange rates remained around current levels. Shares in the FTSE-250 company, which provides outsourced sales and marketing, drug distribution and packaging services to healthcare companies, rose more than 5 percent to a record high of 417.5 pence in morning trade on Tuesday. Dublin-based UDG, formerly known as United Drug, reports results in euros but makes about 70 percent of its profit in pounds and dollars. ... The euro has fallen about 10 percent against the dollar and about 3 percent against the pound since the start of the company's 2015 financial year on Oct. 1. "UDG has left enough room for upgrades through FY15 if positive momentum continues," Jefferies analysts said in a note. The company reported adjusted earnings of 28.77 euro cents per share in the year ended Sept. 30. Average exchange rates were 82 pence and $1.36 to the euro, UDG said. ... "At current exchange rates, we would expect a further 5-6 percent benefit on the bottom line, meaning guidance implies adjusted EPS growth of 10-13 percent for the full year," Berenberg analysts said in a note. Chief Financial Officer Alan Ralph told Reuters the company would take a charge of about 10 million euros this year, related mainly to the restructuring of its healthcare communications business and for changes in its United Drug supply chain unit. The restructuring is expected boost earnings per share by 2 percent in the current financial year and by an additional 1 to 2 percent the following year, Ralph added. UDG shares were up 4.1 percent at 413 pence at 1035 GMT. Shares of the company, which has a market value of about 970 million pounds ($1.46 billion), have gained more than 20 percent since the company reported full-year results in November. ($1 = 0.6641 pounds) (Reporting by Roshni Menon in Bengaluru; Editing by Gopakumar Warrier and Ted Kerr) ((roshni.menon@thomsonreuters.com; within UK +44 20 7542 1810, outside UK +91 80 6749 1136; Reuters Messaging: roshni.menon.thomsonreuters.com@reuters.net;) Keywords: UDG HEALTH OUTLOOK/
UDG UDG Healthcare, gaps up to a new all time high on excellent update this morning. Presently + 5.10% on the day. https://pbs.twimg.com/media/B86mcUbCYAEcgdW.jpg
03 Feb 2015 UDG Healthcare PLC UDG N+1 Singer Buy 414.15 396.70 - - Reiterates
UDG Healthcare sees 5 – 8 pct rise in full – year EPS 03 Feb 2015 - 08:30 (Corrects paragraph 1 to say UDG is based in Ireland, not UK) Feb 3 (Reuters) – Ireland's UDG Healthcare Plc said it had made a strong start to the year and expected adjusted full-year earnings per share to be 5-8 percent ahead of last year on a constant currency basis. The healthcare services provider added that if current exchange rates were sustained for the year, reported EPS would be higher than this range. ... UDG, which reports results in euros, stands to benefit from the recent strengthening of the dollar and sterling against the euro. The company reported adjusted earnings of 28.77 euro cents per share in the year ended Sept. 30, 2014. ... (Reporting by Roshni Menon in Bengaluru; Editing by Gopakumar Warrier) ((roshni.menon@thomsonreuters.com; within UK +44 20 7542 1810, outside UK +91 80 6749 1136; Reuters Messaging: roshni.menon.thomsonreuters.com@reuters.net;) Keywords: UDG HEALTH OUTLOOK/
BRIEF – UDG Healthcare says Q1 trading well ahead of prior year 03 Feb 2015 - 07:19 Feb 3 (Reuters) – UDG Healthcare Plc Has made a strong start to year with trading for quarter to 31 December 2014 well ahead of prior year Expect constant currency adjusted diluted EPS (EPS) for year to 30 September 2015 to be between 5% and 8% ahead of last year Source text for Eikon: ... Further company coverage: UDG.L (Bengaluru Newsroom: +91 806 749 7920;)
UDG WELL AHEAD OF LAST YEAR........ Excelent Trading Update........ UDG HEALTHCARE PLC FIRST QUARTER TRADING UPDATE Strong Start to the Year and Full Year Guidance Issued 3 February 2015: UDG Healthcare plc ("the Group"), a leading international provider of healthcare services issues the following trading update covering the period from 1 October to 31 December 2014. The company will hold its Annual General Meeting in Dublin at 12.00pm today. Quarter to 31 December 2014 Group <b>The Group has made a strong start to the year with trading for the quarter to 31 December 2014 well ahead of the prior year.</b> http://www.investegate.co.uk/udg-healthcare-plc--udg-/rns/1st-quarter-trading-update/201502030700308340D/
2014 – The Great Irish Share Valuation Project (Part I) I take a look at UDG Healthcare, plus a batch of other Irish stocks: http://wexboy.wordpress.com/2014/02/03/2014-the-great-irish-share-valuation-project-part-i/ Cheers, Wexboy
2013 – The Great Irish Share Valuation Project (Part X) I take a look at United Drug, plus a batch of other Irish stocks: http://wexboy.wordpress.com/2013/04/08/2013-the-great-irish-share-valuation-project-part-x/ Cheers, Wexboy
biggy..buy/sell?...